Sector : Health
care
Sub
Sector :
Pharmaceuticals
This comparison would
look into companies that manufacture and distribution of pharmaceutical products.
There are five (5) companies in this industry:
Competitiveness
Market shares is
an importance indicator to determine the competiveness of the company. Total
revenue make from manufacturing and distribution of pharmaceutical products for
the year 2018 is RM 3,994,481,510.
COMPANY
|
REVENUE (PHARMACEUTICAL
PRODUCTS) 2018 (RM)
|
MARKET SHARE
(%)
|
643,557,510
|
16.11
|
|
498,733,000
|
12.49
|
|
178,476,000
|
4.47
|
|
2,384,956,000
|
59.71
|
|
288,759,000
|
7.23
|
PHARMA had the highest market share in manufacturing
and distribution of pharmaceutical products in 2018 which is 59.71 %.
Operational
For operational, operating income of the companies had been review. Operating
income determine how much the companies’ revenue had turn into profit after
reduction cost of operating expense.
Besides operating income, operating margin ratio is
also calculated. Companies with higher operating margin ratio have more
probability to survive in today financial crisis. The median operating margin
ratio for this group of companies for 2018 is 11.57 %.
COMPANY
|
2018 OPERATING
INCOME (RM)
|
2018 OPERATING
MARGIN RATIO
|
68,823,824
|
10.69
|
|
65,824,000
|
13.09
|
|
20,652,000
|
11.57
|
|
106,292,000
|
4.46
|
|
43,537,000
|
15.08
|
PHARMA is having the highest operating margin ration
in this industry.
Sustainability
For the sustainability of the business, debt of the
companies is being review. There are two criteria to look at interest coverageratio,
which is used to determine how easy the companies able to pay off the interest
of outstanding debt and debt ratio.
The
median debt ratio for 2018 is 0.37.
COMPANY
|
2018 INTEREST
COVERAGE RATIO
|
2018 DEBT
RATIO
|
43.02
|
0.28
|
|
8.45
|
0.42
|
|
4.35
|
0.37
|
|
2.95
|
0.72
|
|
10.69
|
0.22
|
AHEALTH and YSPSAH are good companies for sustainability because they
has either high interest coverage ratio and low debt ratio.
Summary
In summary a point is given to each company to evaluate
each company competitiveness, operational and sustainability. Points given are as
follows:
Competitiveness
Criteria
|
Point
|
Greater
than 50 % Market Shares
|
5
|
30.01
% - 50.00 % Market shares
|
4
|
10.01
% - 30.00 % Market shares
|
3
|
5.01
% - 10.00 % Market shares
|
2
|
1.00
% - 5.00 % Market shares
|
1
|
Less
than 1%
|
0
|
Operational
Criteria
|
Point
|
Greater
than 15.00 Operating Margin
|
5
|
12.51
– 15.00 Operating Margin
|
4
|
10.01
– 12.50 Operating Margin
|
3
|
5.01
– 10.00 Operating Margin
|
2
|
1.00
– 5.00 Operating Margin
|
1
|
0.00
– 1.00 Operating Margin
|
0
|
Less
than 0
|
Disqualified
|
Sustainability
Criteria
|
Point
|
No
Financial Cost
|
2
|
Greater
than 10 Interest Coverage Ratio
|
1
|
Less
than 10 Interest Coverage Ratio
|
0
|
Criteria
|
Point
|
Less
than 0.30
|
3
|
0.30
– 0.40
|
2
|
0.40
– 0.50
|
1
|
Greater
than 0.50
|
0
|
COMPANY
|
Competitiveness
|
Operational
|
Sustainability
|
Total
|
3
|
3
|
4
|
10
|
|
3
|
4
|
1
|
8
|
|
1
|
3
|
2
|
6
|
|
5
|
1
|
0
|
6
|
|
2
|
5
|
4
|
11
|
From the evaluation above, YSPSAH (11 points) and
AHEALTH (10 points) are worth for further evaluation.
Summary of Industry Comparison
Hey...Great information thanks for sharing such a valuable information
ReplyDeletePharma shares
Nifty Pharma index
Sun Pharma Limited
Cipla Limited
I think this is one of the most significant information for me. And i’m glad reading your article. But should remark on some general things, The web site style is perfect, the articles is really great : D. Good job, cheers Lorazepam for sale
ReplyDeleteThank you for your feedback
ReplyDelete